Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126302631 | 12630263 | 1 | I | 20160802 | 20160808 | 20160808 | EXP | JP-SA-2016SA142456 | AVENTIS | MUTO M, ICHIKI K, ISHIKAWA C, INOUE M, AOKI T, HASHIMOTO M, ET AL. A CASE OF LARGE CELL NEUROENDOCRINE CARCINOMA OF THE RECTUM. NIHON SHOKAKIBYO GAKKAI ZASSHI. 2015 01;112(4):683-9. | 0.00 | E | F | Y | 47.60000 | KG | 20160808 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126302631 | 12630263 | 1 | SS | CISPLATIN. | CISPLATIN | 1 | Unknown | UNK | 0 | ||||||||||
| 126302631 | 12630263 | 2 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Unknown | UNK | 0 | ||||||||||
| 126302631 | 12630263 | 3 | PS | OXALIPLATIN. | OXALIPLATIN | 1 | Unknown | UNK | 21759 | ||||||||||
| 126302631 | 12630263 | 4 | SS | FOLINIC ACID | LEUCOVORIN | 1 | Unknown | UNK | 0 | ||||||||||
| 126302631 | 12630263 | 5 | SS | IRINOTECAN | IRINOTECAN | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126302631 | 12630263 | 1 | Neuroendocrine carcinoma metastatic |
| 126302631 | 12630263 | 2 | Neuroendocrine carcinoma metastatic |
| 126302631 | 12630263 | 3 | Neuroendocrine carcinoma metastatic |
| 126302631 | 12630263 | 4 | Neuroendocrine carcinoma metastatic |
| 126302631 | 12630263 | 5 | Neuroendocrine carcinoma metastatic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126302631 | 12630263 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126302631 | 12630263 | Disease progression | |
| 126302631 | 12630263 | Neuroendocrine carcinoma metastatic | |
| 126302631 | 12630263 | Product use issue | |
| 126302631 | 12630263 | Treatment failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |